Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy.
CINTESIS@RISE, Faculty of Medicine, The University of Porto, Porto, Portugal.
Expert Rev Gastroenterol Hepatol. 2024 Aug;18(8):421-430. doi: 10.1080/17474124.2024.2397650. Epub 2024 Sep 3.
Although there are well-defined guidelines for the management of mild-to-moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted an international expert consensus to standardize the management of patients with mild-to-moderate UC and provide practical guidance to clinicians.
Based on Delphi methodology, 15 statements were approved after two rounds of voting, addressing several aspects of disease management from sequencing to treatment duration, from monitoring to optimization techniques and safety profile.
Growing knowledge of mild-to-moderate UC has led to the development of new ambitious outcomes such as histological remission and disease clearance. Furthermore, noninvasive tools for patient monitoring such as fecal calprotectin and intestinal ultrasound are now available. Their implementation in clinical practice will allow clinicians to tightly monitor disease activity and promptly adapt treatment, avoiding complications and disease progression and targeting better disease control.
尽管对于轻中度溃疡性结肠炎(UC)的管理有明确的指南,但仍存在未满足的需求。因此,我们进行了一项国际专家共识,以规范轻中度 UC 患者的管理,并为临床医生提供实用的指导。
基于德尔菲法,经过两轮投票,批准了 15 项声明,这些声明涉及疾病管理的多个方面,从治疗顺序到治疗持续时间,从监测到优化技术和安全性。
对轻中度 UC 的认识不断提高,导致出现了新的治疗目标,如组织学缓解和疾病清除。此外,现在还可以使用粪便钙卫蛋白和肠道超声等非侵入性工具来监测患者。在临床实践中应用这些工具可以让临床医生密切监测疾病活动,并及时调整治疗,避免并发症和疾病进展,实现更好的疾病控制。